Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4D | Q08499 | 18/20 | 0.47 |
| ▸ | PDE7B | Q9NP56 | 1/20 | 0.46 |
| ▸ | PDE4A | P27815 | 8/20 | 0.45 |
| ▸ | PDE4B | Q07343 | 8/20 | 0.45 |
| ▸ | PDE4C | Q08493 | 8/20 | 0.45 |
| ▸ | PDE7A | Q13946 | 2/20 | 0.42 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.42 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fumaric Acid SCHEMBL6477040 | 0.89 | PDE4D (0.48) | PDE4DPDE7BPDE4APDE4BPDE4C | |
| Fumaric Acid SCHEMBL6477033 | 0.89 | PDE4D (0.48) | PDE4DPDE7BPDE4APDE4BPDE4C | |
| SCHEMBL6485158 | 0.81 | PDE4D (0.51) | PDE4DPDE7BPDE4APDE4BPDE4C | |
| SCHEMBL7147395 | 0.81 | PDE4D (0.48) | PDE4DPDE7BPDE4APDE4BPDE4C | |
| SCHEMBL6486020 | 0.79 | PDE4D (0.51) | PDE4DPDE7BPDE4APDE4BPDE4C | |
| SCHEMBL6489084 | 0.79 | PDE4D (0.47) | PDE4DPDE7BPDE4APDE4BPDE4C | |
| SCHEMBL4011641 | 0.78 | PDE4D (0.63) | PDE4DPDE7BPDE4APDE4BPDE4C | |
| SCHEMBL2881703 | 0.77 | PDE4D (0.61) | PDE4DPDE7BPDE4APDE4BPDE4C | |
| SCHEMBL6435630 | 0.77 | PDE4D (0.61) | PDE4DPDE7BPDE4APDE4BPDE4C | |
| SCHEMBL6435624 | 0.77 | PDE4D (0.61) | PDE4DPDE7BPDE4APDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6933296-B2 | Compounds effective as β2-adrenoreceptor agonists as well as PDE4-inhibitors | ALTANA PHARMA B.V. (NL) | 2005-08-23 | — | — | US | disclosed |
| EP-1296956-A1 | COMPOUNDS EFFECTIVE AS BETA-2-ADRENORECEPTOR AGONISTS AS WELL AS PDE4-INHIBITORS | ALTANA Pharma AG (DE) | 2003-04-02 | — | — | EP | disclosed |
| WO-2001094319-A1 | COMPOUNDS EFFECTIVE AS BETA-2-ADRENORECEPTOR AGONISTS AS WELL AS PDE4-INHIBITORS | ALTANA PHARMA AG (DE) | 2001-12-13 | — | — | WO | disclosed |